Familial Breast Cancer

Risk to the Contralateral Breast

Randall E. Harris, Henry T. Lynch, Hoda A. Guirgis

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Pathology reports of 198 familial breast cancer patients were reviewed to determine chronologic features of tumorigenesis in the breast contralateral to the site of initial mastectomy. Actuarial data revealed two major risk periods with a prolonged intervening postoperative gap in which no malignant tumors of the contralateral breast were detected. The cumulative cancer risk to the contralateral breast increased annually at 2.8% in the first 6 postoperative years, then showed no increase in the next 7 years, and finally resumed its upward climb at an accentuated annual rate of 6.8% between years 13 and 16 (inclusive). The corresponding annual rates of increase for second primary breast cancer in the two risk periods were 1.6 and 5.9%, respectively. A total of 37 patients manifested bilateral breast cancer, of whom 21 had pathologically confirmed second primary carcinomas, i.e., primary tumors of the contralateral breast. Of these patients, 27 exhibited a relatively short interval between mastectomies (x=1.7 yr), whereas 10 had a much longer disease-free period (x=16.5 yr). It is likely that tumors manifested in the contralateral breast within 6 years of the initial breast cancer were already developing but were not clinically discernible at the time of first mastectomy. In contrast, the extended disease-free period of many patients suggests that host defense mechanisms may have been stimulated by the first tumor, which in turn had a persisting suppressive effect on de novo carcinogenesis in the contralateral breast. Our results underscore the need for vigorous cancer surveillance of long-term survivors of an initial breast cancer, particularly in familial patients.

Original languageEnglish
Pages (from-to)955-960
Number of pages6
JournalJournal of the National Cancer Institute
Volume60
Issue number5
DOIs
StatePublished - 1978

Fingerprint

Breast
Breast Neoplasms
Mastectomy
Neoplasms
Carcinogenesis
Second Primary Neoplasms
Survivors
Familial Breast Cancer
Pathology
Carcinoma

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Oncology

Cite this

Familial Breast Cancer : Risk to the Contralateral Breast. / Harris, Randall E.; Lynch, Henry T.; Guirgis, Hoda A.

In: Journal of the National Cancer Institute, Vol. 60, No. 5, 1978, p. 955-960.

Research output: Contribution to journalArticle

Harris, Randall E. ; Lynch, Henry T. ; Guirgis, Hoda A. / Familial Breast Cancer : Risk to the Contralateral Breast. In: Journal of the National Cancer Institute. 1978 ; Vol. 60, No. 5. pp. 955-960.
@article{4b0bf4d786614ee585c2e680ec4aaa88,
title = "Familial Breast Cancer: Risk to the Contralateral Breast",
abstract = "Pathology reports of 198 familial breast cancer patients were reviewed to determine chronologic features of tumorigenesis in the breast contralateral to the site of initial mastectomy. Actuarial data revealed two major risk periods with a prolonged intervening postoperative gap in which no malignant tumors of the contralateral breast were detected. The cumulative cancer risk to the contralateral breast increased annually at 2.8{\%} in the first 6 postoperative years, then showed no increase in the next 7 years, and finally resumed its upward climb at an accentuated annual rate of 6.8{\%} between years 13 and 16 (inclusive). The corresponding annual rates of increase for second primary breast cancer in the two risk periods were 1.6 and 5.9{\%}, respectively. A total of 37 patients manifested bilateral breast cancer, of whom 21 had pathologically confirmed second primary carcinomas, i.e., primary tumors of the contralateral breast. Of these patients, 27 exhibited a relatively short interval between mastectomies (x=1.7 yr), whereas 10 had a much longer disease-free period (x=16.5 yr). It is likely that tumors manifested in the contralateral breast within 6 years of the initial breast cancer were already developing but were not clinically discernible at the time of first mastectomy. In contrast, the extended disease-free period of many patients suggests that host defense mechanisms may have been stimulated by the first tumor, which in turn had a persisting suppressive effect on de novo carcinogenesis in the contralateral breast. Our results underscore the need for vigorous cancer surveillance of long-term survivors of an initial breast cancer, particularly in familial patients.",
author = "Harris, {Randall E.} and Lynch, {Henry T.} and Guirgis, {Hoda A.}",
year = "1978",
doi = "10.1093/jnci/60.5.955",
language = "English",
volume = "60",
pages = "955--960",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Familial Breast Cancer

T2 - Risk to the Contralateral Breast

AU - Harris, Randall E.

AU - Lynch, Henry T.

AU - Guirgis, Hoda A.

PY - 1978

Y1 - 1978

N2 - Pathology reports of 198 familial breast cancer patients were reviewed to determine chronologic features of tumorigenesis in the breast contralateral to the site of initial mastectomy. Actuarial data revealed two major risk periods with a prolonged intervening postoperative gap in which no malignant tumors of the contralateral breast were detected. The cumulative cancer risk to the contralateral breast increased annually at 2.8% in the first 6 postoperative years, then showed no increase in the next 7 years, and finally resumed its upward climb at an accentuated annual rate of 6.8% between years 13 and 16 (inclusive). The corresponding annual rates of increase for second primary breast cancer in the two risk periods were 1.6 and 5.9%, respectively. A total of 37 patients manifested bilateral breast cancer, of whom 21 had pathologically confirmed second primary carcinomas, i.e., primary tumors of the contralateral breast. Of these patients, 27 exhibited a relatively short interval between mastectomies (x=1.7 yr), whereas 10 had a much longer disease-free period (x=16.5 yr). It is likely that tumors manifested in the contralateral breast within 6 years of the initial breast cancer were already developing but were not clinically discernible at the time of first mastectomy. In contrast, the extended disease-free period of many patients suggests that host defense mechanisms may have been stimulated by the first tumor, which in turn had a persisting suppressive effect on de novo carcinogenesis in the contralateral breast. Our results underscore the need for vigorous cancer surveillance of long-term survivors of an initial breast cancer, particularly in familial patients.

AB - Pathology reports of 198 familial breast cancer patients were reviewed to determine chronologic features of tumorigenesis in the breast contralateral to the site of initial mastectomy. Actuarial data revealed two major risk periods with a prolonged intervening postoperative gap in which no malignant tumors of the contralateral breast were detected. The cumulative cancer risk to the contralateral breast increased annually at 2.8% in the first 6 postoperative years, then showed no increase in the next 7 years, and finally resumed its upward climb at an accentuated annual rate of 6.8% between years 13 and 16 (inclusive). The corresponding annual rates of increase for second primary breast cancer in the two risk periods were 1.6 and 5.9%, respectively. A total of 37 patients manifested bilateral breast cancer, of whom 21 had pathologically confirmed second primary carcinomas, i.e., primary tumors of the contralateral breast. Of these patients, 27 exhibited a relatively short interval between mastectomies (x=1.7 yr), whereas 10 had a much longer disease-free period (x=16.5 yr). It is likely that tumors manifested in the contralateral breast within 6 years of the initial breast cancer were already developing but were not clinically discernible at the time of first mastectomy. In contrast, the extended disease-free period of many patients suggests that host defense mechanisms may have been stimulated by the first tumor, which in turn had a persisting suppressive effect on de novo carcinogenesis in the contralateral breast. Our results underscore the need for vigorous cancer surveillance of long-term survivors of an initial breast cancer, particularly in familial patients.

UR - http://www.scopus.com/inward/record.url?scp=0018142585&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018142585&partnerID=8YFLogxK

U2 - 10.1093/jnci/60.5.955

DO - 10.1093/jnci/60.5.955

M3 - Article

VL - 60

SP - 955

EP - 960

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 5

ER -